Skip to main content
William Mobley, MD, Child Neurology, San Diego, CA, UC San Diego Medical Center - Hillcrest

WilliamCMobleyMD

Child Neurology • San Diego, CA

Professor and Chair of the Department of Neurosciences; Executive Director, Down Syndrome Center for Research and Treatment; and Florence Riford Chair of Alzheimer Disease Research at University of California, San Diego (UCSD).

Join to view full profile

Dr. Mobley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Mobley's full profile

Already have an account?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Neurology, 1979 - 1982
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Pediatrics, 1977 - 1979
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityInternship, Pediatrics, 1976 - 1977
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 1976

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1978 - 2025
  • MD State Medical License
    MD State Medical License 1983 - 1985
  • American Board of Pediatrics Pediatrics
  • American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology

Awards, Honors, & Recognition

  • Elected Member Institute of Medicine, 2004

Publications & Presentations

PubMed

Press Mentions

  • Alzheon to Present ALZ-801 (Valiltramiprosate) Oral Tablet Program Update as Potential Treatment for Alzheimer’s Disease in Adults with down Syndrome at 4th International Trisomy 21 Research Conference
    Alzheon to Present ALZ-801 (Valiltramiprosate) Oral Tablet Program Update as Potential Treatment for Alzheimer’s Disease in Adults with down Syndrome at 4th International Trisomy 21 Research ConferenceJune 7th, 2022
  • Big Bucks for Burnout: Can $155M Solve the Problem?
    Big Bucks for Burnout: Can $155M Solve the Problem?August 14th, 2019
  • AC Immune Hosts KOL Event and Reports Initial Interim Clinical Data for ACI-24 Vaccine to Treat Alzheimer’s Disease-like Symptoms in Subjects with down Syndrome
    AC Immune Hosts KOL Event and Reports Initial Interim Clinical Data for ACI-24 Vaccine to Treat Alzheimer’s Disease-like Symptoms in Subjects with down SyndromeJuly 11th, 2019
  • Join now to see all

Grant Support

  • Genetic Basis Of Failed Cognition In Young And Aged Mouse Models Of Trisomy 21National Institute Of Neurological Disorders And Stroke2010–2011
  • Neuronal Axons (Axons From DRG Neurons)National Center For Research Resources2010–2011
  • Disrupted Transport Of Ngf-Trka Signaling In Mouse Models Of DOWN SyndromeNational Institute Of Neurological Disorders And Stroke2009–2010
  • 2009 Neurotrophic Factors Gordon Research ConferenceNational Institute Of Neurological Disorders And Stroke2009
  • Disrupted Transport Of Ngf-Trka Signaling In Mouse Models Of DOWN SyndromeNational Institute Of Neurological Disorders And Stroke2007–2009
  • Nerve Growth Factor-Mechanisms For Signal TransductionNational Institute Of Neurological Disorders And Stroke2004–2008
  • Training In Translational Develomental NeuroscienceNational Institute Of Neurological Disorders And Stroke2004–2007
  • Mapping DS Related CNS PhenotypesNational Institute Of Neurological Disorders And Stroke1999–2002
  • NGF Signaling In Models Of Age Related NeurodegenerationNational Institute On Aging1998–2002
  • Nerve Growth Factor--Mechanisms For Signal TransductionNational Institute Of Neurological Disorders And Stroke1998–1999
  • Neurological Disorders Program Project Review CommitteeNational Institute Of Neurological Disorders And Stroke1997–1998
  • Nerve Growth Factor--Mechanisms For Signal TransductionNational Institute Of Neurological Disorders And Stroke1995–1997
  • Defining The Molecular Basis For The Trisomy 16 CNS PhenotypeNational Institute On Aging1994–1997
  • Neurological Sciences Academic Development AwardNational Institute Of Neurological Disorders And Stroke1993–1996
  • Neurotrophic Factor Therapy For Alzheimers DiseaseNational Institute On Aging1994–1995
  • Neurotrophic Factor Therapy For Alzheimer'S DiseaseNational Institute On Aging1991–1993
  • Nerve Growth Factor--Trophic Effects On CNS NeuronsNational Institute Of Neurological Disorders And Stroke1986–1993
  • Nerve Growth Factor--Effects On Developing CNS NeuronsNational Institute Of Neurological Disorders And Stroke1985–1987

Hospital Affiliations

Dr. William Mobley, Dr. William Mobley, MD, Dr. W Mobley, Dr. William C Mobley